<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
(Rule 13d-101)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a)
AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a)
TARGETED GENETICS CORPORATION
- --------------------------------------------------------------------------------
(Name of Issuer)
COMMON STOCK, $.01 PAR VALUE PER SHARE
- --------------------------------------------------------------------------------
(Title of Class of Securities)
87612M 10 8
- --------------------------------------------------------------------------------
(CUSIP Number)
James A. Johnson
Targeted Genetics Corporation
1100 Olive Way, Suite 100
Seattle, Washington 98101
(206) 623-7612
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
April 17, 1998
- --------------------------------------------------------------------------------
(Date of Event Which Requires Filing
of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box. [ ]
Page 1 of 11 pages
<PAGE> 2
SCHEDULE 13D
CUSIP NO. 87612M 10 8 PAGE 2 OF 11 PAGES
- --------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSON
THE EQUITABLE LIFE ASSURANCE SOCIETY
- --------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [ ]
2 (b) [ ]
- --------------------------------------------------------------------------------
SEC USE ONLY
3
- --------------------------------------------------------------------------------
SOURCE OF FUNDS*
4
WC
- --------------------------------------------------------------------------------
CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
5 ITEMS 2(d) or 2(E) [ ]
- --------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
6
UNITED KINGDOM
- --------------------------------------------------------------------------------
SOLE VOTING POWER
7
3,000,000
NUMBER OF ----------------------------------------------------------------
SHARES SHARED VOTING POWER
BENEFICIALLY 8
OWNED BY ----------------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
REPORTING 9
PERSON 3,000,000
WITH ----------------------------------------------------------------
SHARED DISPOSITIVE POWER
10
- --------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
3,000,000
- --------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES* [ ]
- --------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
10.03% (1)
- --------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- --------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
-2-
<PAGE> 3
NOTES TO SCHEDULE 13D FOR
TARGETED GENETICS CORPORATION
(1) Percentage is based upon 28,883,381 shares of Common Stock outstanding
as of April 17, 1998.
-3-
<PAGE> 4
ITEM 1. SECURITY AND ISSUER.
This Schedule 13D relates to the Common Stock, par value $.01 per share
("Common Stock"), of Targeted Genetics Corporation, a Washington corporation
("Targeted Genetics"), the principal executive office of which is located at
1100 Olive Way, Suite 100, Seattle, Washington 98101.
ITEM 2. IDENTITY AND BACKGROUND.
This Schedule 13D is filed on behalf of The Equitable Life Assurance
Society, a company formed under the laws of the United Kingdom ("Equitable"),
pursuant to Rule 13d-1(a) under the Securities Exchange Act of 1934, as amended
(the "Exchange Act"). Equitable owns 3,000,000 shares of Common Stock of
Targeted Genetics (the "Equitable Shares"). Equitable's principal business is
life assurance and pensions principally in the United Kingdom. The principal
business address and the principal office address of Equitable is City Place
House, 55 Basinghall Street, London EC2V 5DR, England.
(d), (e) Equitable has not during the last five years, (i) been
convicted in a criminal proceeding (excluding traffic violations or similar
misdemeanors) or (ii) been a party to a civil proceeding of a judicial or
administrative body of competent jurisdiction and as a result of such proceeding
was or is subject to a judgment, decree or final order enjoining future
violations of, or prohibiting or mandating activities subject to, federal or
state securities laws or finding any violation with respect to such laws.
OFFICERS AND DIRECTORS OF REPORTING PERSON:
(a) Name: PETER ANTHONY DAVIS
(b) Business Address: 29 Arthur Road
London SW19 7DN
England
(c) Principal Occupation,
Name of Business, Principal
Business and Address: Accountant
Director of Equitable
29 Arthur Road
London SW19 7DN
England
(d) Criminal Proceedings:None
(e) Civil Proceedings: None
-4-
<PAGE> 5
(f) Citizenship: British
(a) Name: PETER MARTIN
(b) Residence Address: Knighton Cottage
Knighton
Swindon
Wilts SN6 8NT
England
(c) Principal Occupation,
Name of Business, Principal
Business and Address: Solicitor, Retired
Director of Equitable
(d) Criminal Proceedings: None
(e) Civil Proceedings: None
(f) Citizenship: British
(a) Name: ALAN NASH
(b) Business Address: The Equitable Life Assurance Society
Walton Street
Aylesbury Bucks HP21 7QW
England
(c) Principal Occupation,
Name of Business, Principal
Business and Address: General Manager - Finance and a
Director of Equitable
The Equitable Life Assurance Society
Walton Street
Aylesbury Bucks HP21 7QW
England
(d) Criminal Proceedings: None
(e) Civil Proceedings: None
(f) Citizenship: British
(a) Name: JENNIFER ANNE PAGE
-5-
<PAGE> 6
(b) Business Address: The New Millenium Experience Company Ltd.
110 Buckingham Palace Road
London SW1W 9SB
England
(c) Principal Occupation,
Name of Business, Principal
Business and Address: Chief Executive
The New Millenium Experience Company
110 Buckingham Palace Road
London SW1W 9SB
England
(d) Criminal Proceedings: None
(e) Civil Proceedings: None
(f) Citizenship: British
(a) Name: DAVID WILLIAM JAMES PRICE
(b) Business Address: Mercury Asset Management plc
33 King William Street
London EC4R 9AS
England
(c) Principal Occupation,
Name of Business, Principal
Business and Address: Deputy Chairman
Director of Equitable
Mercury Asset Management plc
33 King William Street
London EC4R 9AS
England
(d) Criminal Proceedings: None
(e) Civil Proceedings: None
(f) Citizenship: British
(a) Name: JOHN RICHARD SCLATER
(b) Business Address: 117 Eaton Square
London SW1W 9AA
-6-
<PAGE> 7
England
(c) Principal Occupation,
Name of Business, Principal
Business and Address: Banker
Director of Equitable
117 Eaton Square
London SW1W 9AA
England
(d) Criminal Proceedings: None
(e) Civil Proceedings: None
(f) Citizenship: British
(a) Name: IAN PETER SEDGWICK
(b) Business Address: Schroeders plc
120 Cheapside
London EC2V 6DS
England
(c) Principal Occupation,
Name of Business, Principal
Business and Address: Vice Chairman
Director of Equitable
Schroeders plc
120 Cheapside
London EC2V 6DS
England
(d) Criminal Proceedings: None
(e) Civil Proceedings: None
(f) Citizenship: British
(a) Name: JONATHAN FRANCIS TAYLOR
(b) Business Address: Booker plc
85 Buckingham Gate
London SW1E 6PD
England
-7-
<PAGE> 8
(c) Principal Occupation,
Name of Business, Principal
Business and Address: Chairman
Director of Equitable
Booker plc
85 Buckingham Gate
London SW1E 6PD
England
(d) Criminal Proceedings: None
(e) Civil Proceedings: None
(f) Citizenship: British
(a) Name: DAVID GEORGE THOMAS
(b) Business Address: The Equitable Life Assurance Society
City Place House
55 Basinghall Street
London EC2V 5DR
England
(c) Principal Occupation,
Name of Business, Principal
Business and Address: General Manager - Investments and
a Director of Equitable
The Equitable Life Assurance Society
City Place House
55 Basinghall Street
London EC2V 5DR
England
(d) Criminal Proceedings: None
(e) Civil Proceedings: None
(f) Citizenship: British
(a) Name: ALAN GEORGE TRITTON
(b) Residence Address: Lyons Hall
Great Leighs
Chelmsford
-8-
<PAGE> 9
Essex CH3 1PL
England
(c) Principal Occupation,
Name of Business, Principal
Business and Address: Retired
Director of Equitable
(d) Criminal Proceedings: None
(e) Civil Proceedings: None
(f) Citizenship: British
(a) Name: DAVID WILLIAM WILSON
(b) Business Address: Wilson Bowden plc
Wilson Bowden House
Leicester Road
Ibstock
Leicester LE67 6HP
England
(c) Principal Occupation,
Name of Business, Principal
Business and Address: Chairman
Director of Equitable
Wilson Bowden plc
Wilson Bowden House
Leicester Road
Ibstock
Leicester LE67 6HP
England
(d) Criminal Proceedings: None
(e) Civil Proceedings: None
(f) Citizenship: British
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION.
On April 17, 1998, the Reporting Person was issued 2,000,000 shares of
Targeted Genetics' Common Stock and a warrant to purchase an additional
1,000,000 shares of Common Stock for $3,000,000 pursuant to an offering by
Targeted Genetics under
-9-
<PAGE> 10
Regulation D to qualified institutional investors. The shares were acquired with
working capital.
ITEM 4. PURPOSE OF TRANSACTION.
The shares were acquired for investment purposes.
(a)-(j) None
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER.
(a) The 3,000,000 shares held by Equitable represent 10.03% of the
28,883,381 shares of Common Stock of Targeted Genetics outstanding on the date
hereof, based upon information provided by Targeted Genetics and calculated in
accordance with Rule 13d-3(d)(1) under the Exchange Act.
(b) Equitable has the sole power to vote or direct the voting of and to
dispose of or direct the disposition of the Equitable Shares.
(c) Except as set forth in this Schedule 13D, neither Equitable nor, to
the best of the knowledge of Equitable, any of the officers or directors of
Equitable named herein, owns any shares of the capital stock of Targeted
Genetics or has purchased or sold any shares of the capital stock of Targeted
Genetics during the past 60 days
(d) Except as set forth in this Schedule 13D, no person is known by
Equitable to have the right to receive or the power to direct the receipt of
dividends from, or the proceeds from the sale of, the Equitable Shares.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT
TO SECURITIES OF THE ISSUER.
None.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS.
None.
-10-
<PAGE> 11
SIGNATURES
After reasonable inquiry and to the best knowledge and belief of the
undersigned, the undersigned certifies that the information set forth in this
statement is true, complete and correct and agrees that this statement is filed
on behalf of the undersigned.
Dated: April 27, 1998
THE EQUITABLE LIFE ASSURANCE SOCIETY
By /s/ Charles Edward Duddridge
-------------------------------------------
Its Assistant General Manager Securities and
Investments
-11-
